COVID-19 vaccine data show low risk from third shot as cases decline
The Biden administration’s COVID-19 booster shot campaign is off to a promising start, with about 1 million Americans signed up to receive a third Pfizer dose at pharmacies in the coming weeks, and adverse reactions to booster shots are rare, according to new Centers for Disease Control and Prevention data released Tuesday.